Last updated
ResMed: M&A Activity
ResMed facing ventilator issues that could cloud FY27 performance, despite otherwise strong earnings growth outlook
Source: GN — ASX:RMD Resmed
- Who
- ResMed · Australia & New Zealand
- What happened
- ResMed facing ventilator issues that could cloud FY27 performance, despite otherwise strong earnings growth outlook
- When
- 2026-07-21
- Source
- GN — ASX:RMD Resmed
- So what
- ResMed's ventilator segment is now a disclosed risk against an otherwise credible earnings growth thesis, which means the company has moved from managing a product category to managing an investor narrative around one.
The leadership read
ResMed's ventilator segment is now a disclosed risk against an otherwise credible earnings growth thesis, which means the company has moved from managing a product category to managing an investor narrative around one. That shift carries real operational weight: ventilator revenue sits at the intersection of hospital procurement cycles, reimbursement dynamics, and clinical regulatory scrutiny, each of which moves on a different timeline than the CPAP and sleep-therapy businesses that dominate the ASX story. A cloud over FY27 guidance in that segment forces active portfolio triage, which products receive capital allocation, which commercial relationships get priority attention, and whether the regulatory posture around the ventilator line is adequate for the exposure it now represents. The related-signals set for this period is 12 M&A events across 90 days, but they are largely cross-sector and do not constitute a coherent medtech pattern. The honest read is that this signal stands mostly alone. The closer comparables are Amneal's biosimilar integration and Skylight's IP acquisition, both medtech-adjacent, both about resolving product-portfolio complexity through transaction or capability consolidation rather than organic remediation. Where the pattern does hold across medtech companies navigating product-line risk of this type is in the functional premium it places on regulatory affairs leadership, reimbursement strategy, and the commercial operations capability to protect core revenue while a secondary line is under pressure. The market is moving toward operators who can run parallel tracks: defending the core commercial story while managing a contained but visible product risk to closure.
Market context: MitchelLake's Talent Market Index sits at 95.4 (Cool), down 5.3 on the prior month; Oceania hiring signal is running rising (+8.2pts).
ResMed: 3 signals in the last 90 days; 0.1% of MitchelLake's EMEA signal flow; 9 tracked across 182 days.
MitchelLake in this thematic
Also at ResMed →
More signals across Oceania
M&A Activity · Oceania
SGHiscock →SGHiscock will acquire Bell Asset Management, combining two Melbourne-based active fund managers to gain scale.
M&A Activity · Oceania
Oliver Wyman →Oliver Wyman, a wholly owned subsidiary of Marsh McLennan, has acquired an unnamed global technology consulting and AI platform company that serves wealth managers and other financial services organisations, including operations in Australia.
M&A Activity · Oceania
Accent Group →Accent Group (owner of Platypus) board is defending against an unsolicited takeover bid from British billionaire Mike Ashley, urging shareholders to reject it.
M&A Activity · Oceania
OtherPay →OtherPay and Securely Group have signed Heads of Terms to explore a strategic business combination aimed at creating an Australian global payments and digital-trust group.
M&A Activity · Oceania
Black Milk Clothing →Collapsed Brisbane-founded fashion brand Black Milk Clothing was acquired out of voluntary administration by Factory X, owner of Gorman, Dangerfield and Princess Highway. Administrator was Apex Advisory.
M&A Activity · Oceania
Frasers Group Plc →Frasers Group is pursuing a takeover of Australian retailer Accent Group Ltd. Its finance chief publicly attacked Accent's performance and demanded the chairman resign at Accent's annual meeting in Melbourne.
Where this lands in our work
- Private Equity →
Ownership change resets the executive requirement — value-creation leadership follows the deal.
- Executive Search: Oceania →
Our Oceania practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
